HomeScienceMIRAM® KitClinical StudiesNewsTeamCareersContact

News

All newsPress Releases
The Roddenberry Foundation Awards Elypta $1 Million Grand Prize
Mar 28, 2023

The Roddenberry Foundation Awards Elypta $1 Million Grand Prize

Study in JCO Precision Oncology shows promising results supporting the use of glycosaminoglycan profiles (GAGomes) for monitoring and predicting response in patients with metastatic renal cell carcinoma
Mar 15, 2023

Study in JCO Precision Oncology shows promising results supporting the use of glycosaminoglycan profiles (GAGomes) for monitoring and predicting response in patients with metastatic renal cell carcinoma

Double multi-cancer detection rate shown in the earliest stage using Elypta MIRAM® kit
Dec 7, 2022

Double multi-cancer detection rate shown in the earliest stage using Elypta MIRAM® kit

Elypta recognized as one of Sweden's best start-ups
Oct 20, 2022

Elypta recognized as one of Sweden's best start-ups

Elypta selected as one of the Winners of Falling Walls Venture 2022
Aug 17, 2022

Elypta selected as one of the Winners of Falling Walls Venture 2022

Elypta appoints Volker Liebenberg as CMO
Aug 10, 2022

Elypta appoints Volker Liebenberg as CMO

Elypta raises $21 million Series A to develop metabolism-based multi-cancer early detection test
Jun 20, 2022

Elypta raises $21 million Series A to develop metabolism-based multi-cancer early detection test

Elypta launches Multi-Cancer Early Detection study to measure metabolic GAGome levels in adults at high risk of cancer in collaboration with the University of Leeds and Yorkshire Cancer Research
Apr 4, 2022

Elypta launches Multi-Cancer Early Detection study to measure metabolic GAGome levels in adults at high risk of cancer in collaboration with the University of Leeds and Yorkshire Cancer Research

Elypta launches Multi-Cancer Early Detection screening study measuring metabolic GAGome levels in asymptomatic adults
Feb 15, 2022

Elypta launches Multi-Cancer Early Detection screening study measuring metabolic GAGome levels in asymptomatic adults

Pivotal AUR87A study of GAGome-based liquid biopsy for kidney cancer recurrence opens 26th site
Dec 15, 2021

Pivotal AUR87A study of GAGome-based liquid biopsy for kidney cancer recurrence opens 26th site

Elypta extends range of GAGome-based liquid biopsy applications
Dec 8, 2021

Elypta extends range of GAGome-based liquid biopsy applications

100th enrolled patient and more positive news
Jul 1, 2021

100th enrolled patient and more positive news

Elypta to present detection of any-stage cancer results at ASCO 2021
Jun 1, 2021

Elypta to present detection of any-stage cancer results at ASCO 2021

Elypta launches research service for glycosaminoglycan profiling
Feb 3, 2021

Elypta launches research service for glycosaminoglycan profiling

Elypta granted US patent for its liquid biopsy method based on cancer metabolism
Jan 28, 2021

Elypta granted US patent for its liquid biopsy method based on cancer metabolism

AUR87A attracts interest at renowned urological congresses
Nov 27, 2020

AUR87A attracts interest at renowned urological congresses

AUR87A October 2020 update
Oct 14, 2020

AUR87A October 2020 update

Ethics approval completed in all countries
Sep 15, 2020

Ethics approval completed in all countries

Elypta among Sweden's best 33 tech start-ups
Sep 10, 2020

Elypta among Sweden's best 33 tech start-ups

Elypta HQ moves to Karolinska Institute campus
Sep 9, 2020

Elypta HQ moves to Karolinska Institute campus

MilliporeSigma announced as contract manufacturer of Elypta's kits
Feb 18, 2020

MilliporeSigma announced as contract manufacturer of Elypta's kits

Elypta among Nature Research and Merck's 44 spin-offs to watch
Feb 18, 2020

Elypta among Nature Research and Merck's 44 spin-offs to watch

First patient enrolled in Elypta’s pioneering AUR87A renal cell carcinoma liquid biopsy trial
Feb 11, 2020

First patient enrolled in Elypta’s pioneering AUR87A renal cell carcinoma liquid biopsy trial

Elypta raises €6.1 million in a late seed round led by Industrifonden
Jan 23, 2020

Elypta raises €6.1 million in a late seed round led by Industrifonden

Francesco Gatto wins SKAPA-priset
Nov 15, 2019

Francesco Gatto wins SKAPA-priset

Elypta wins Nordic Life Science Award 2019
Sep 11, 2019

Elypta wins Nordic Life Science Award 2019

Elypta announces initiation of the pivotal AURORAX-087A study
Sep 6, 2019

Elypta announces initiation of the pivotal AURORAX-087A study

Elypta nominated for Best Technological Innovation in Diagnostics by Medtech Insight
Aug 16, 2019

Elypta nominated for Best Technological Innovation in Diagnostics by Medtech Insight

Elypta met with the FDA regarding AUR87A
Jul 23, 2019

Elypta met with the FDA regarding AUR87A

Elypta named Nordic start-up of the year in the Serendipity Challenge
Jul 2, 2019

Elypta named Nordic start-up of the year in the Serendipity Challenge

Elypta in final top 50 of the Serendipity Challenge
Jun 17, 2019

Elypta in final top 50 of the Serendipity Challenge

Elypta visited by Dr Robert Langer
May 15, 2019

Elypta visited by Dr Robert Langer

Genetic Engineering News places Francesco Gatto among top 10 rising stars under 40
May 7, 2019

Genetic Engineering News places Francesco Gatto among top 10 rising stars under 40

AURORAX project co-funded by the European Union started on May 1st
May 6, 2019

AURORAX project co-funded by the European Union started on May 1st

Elypta participated in the Swedish American Life Science Summit in Washington DC
Apr 10, 2019

Elypta participated in the Swedish American Life Science Summit in Washington DC

Elypta interviewed on BBC podcast - The Naked Scientist
Mar 27, 2019

Elypta interviewed on BBC podcast - The Naked Scientist

Elypta selected to present at BIO Europe Spring Start-up spotlight
Mar 8, 2019

Elypta selected to present at BIO Europe Spring Start-up spotlight

In-depth article on Elypta in 360Dx
Feb 27, 2019

In-depth article on Elypta in 360Dx

Elypta awarded €2.35 million from Horizon 2020 SME instrument
Feb 4, 2019

Elypta awarded €2.35 million from Horizon 2020 SME instrument

Francesco Gatto recognized as the top pioneer among Innovators under 35 in Europe
Dec 10, 2018

Francesco Gatto recognized as the top pioneer among Innovators under 35 in Europe

Francesco Gatto recognized among Europe's top 35 Innovators Under 35
Nov 6, 2018

Francesco Gatto recognized among Europe's top 35 Innovators Under 35

Elypta again named among world's top 500 DeepTech start-ups
Oct 24, 2018

Elypta again named among world's top 500 DeepTech start-ups

Elypta receives EIT Health Digital Sandbox grant
Oct 12, 2018

Elypta receives EIT Health Digital Sandbox grant

Francesco Gatto interviewed by Labiotech.eu
Jun 22, 2018

Francesco Gatto interviewed by Labiotech.eu

Anders Ekblom joins Elypta's board of directors
Feb 20, 2018

Anders Ekblom joins Elypta's board of directors

Elypta among Top 500 Deep-Tech Startups
Jul 14, 2017

Elypta among Top 500 Deep-Tech Startups

Backed by
Industrifonden LogoChalmers VenturesNorrsken VCEU

Advance cancer detection with us

Collaborations

We welcome partnerships with academia to explore clinical applications as well as industry for the development of companion diagnostics.

Learn more

Investors

We welcome interest from investors and are happy to provide more information on our plans on request.

Get in touch

Join the team

We are always looking to interact with top talents interested in joining our development team.

Learn more
+46 (0)8 520 27 885info@elypta.com

Elypta AB, Nanna Svartz väg 4, 171 65 Solna, Sweden

ScienceMIRAM® KitClinical StudiesNewsTeamCareersContact